Patient info Open main menu

Methocarbamol Aristo 750 mg tablet – patient leaflet, side effects, dosage

Last updated: · Text from the MHRA, as of · About this document

Medicine status: Prescription only (POM) Details

Medicine strength:
750 mg
Contains active substance:
Similar medicines:

Patient leaflet - Methocarbamol Aristo 750 mg tablet

1. What Methocarbamol is and what it is used for

Methocarbamol tablets contain the active substance methocarbamol. Methocarbamol belongs to a group of medications described as muscle relaxants.

Methocarbamol is used for the

symptomatic treatment of painful muscle spasms, especially in the lower back (lumbago).

Methocarbamol is used in adults.

2. What you need to know before you take Methocarbamol

Do not take Methocarbamol

  • if you are allergic to methocarbamol or any of the other ingredients of this medicine (listed in section 6).
  • if you have ever suffered from a coma or reduced consciousness.
  • if you suffer from any disorders of the central nervous system.
  • if you suffer from abnormal muscle weakness (known as ‘Myasthenia gravis’)
  • if you suffer from epileptic seizures

Warnings and precautions

Talk to your doctor or pharmacist before taking Methocarbamol

  • if you suffer from kidney and/or liver problems.

Interactions with laboratory tests Methocarbamol may cause colour interference in certain screening tests (for hydroxindolacetic acid [5-HIAA] and for vanilylmandelic acid [VMA]. The urine of some patients receiving methocarbamol has been reported to turn brown, black, blue or green when stored.

Use in children and adolescents

This medicine is not recommended for use in children aged to 12 years and adolescents due to a lack of data.

Other medicines and Methocarbamol

Tell your doctor or pharmacist if you are taking, have recently taken/used or might take/use any other medicines including medicines obtained without prescription.

Taking Methocarbamol at the same time as certain medicines such as barbiturates, opioids or appetite suppressants may increase the effect of these medicines.

The effects of anticholinergics, e.g. atropine and other psychotropic drugs may be increased by Methocarbamol.

Methocarbamol may decrease the effect of pyridostigmine bromide. Therefore methocarbamol must not be used in patients with abnormal muscle weakness (myasthenia gravis), especially those being treated with pyridostigmine.

Methocarbamol with alcohol

Alcohol may increase the effects of methocarbamol.

Pregnancy, breast-feeding and fertility

If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.

Pregnancy

If you are pregnant you should not take this medicine since the safe use of Methocarbamol has not been established.

Breast-feeding

It is not known whether methocarbamol and/or its metabolites are passed into human milk. Therefore, you should not use this medicine if you are breast-feeding.

Fertility

No data are available about the effects of Methocarbamol on human fertility.

Driving and using machines

Methocarbamol may affect your ability to drive and use machines. Before driving or using machines, you should consider your general health and the possible side effects of Methocarbamol (see section 4) and you should not drive or use machines if you experience any side effects such as dizziness or sleepiness.

Methocarbamol tablets contain sodium

This medicine contains less than 1 mmol sodium (23 mg) per tablet, that is to say essentially ‘sodium-free’.

3. How to take Methocarbamol

Always take this medicine exactly as your doctor has told you. You should check with your doctor or pharmacist if you are not sure.

Adults

Unless otherwise prescribed, the recommended dosage is 2 tablets taken three times a day. At the start of treatment, it is recommended to take 2 tablets four times a day.

In severe cases, up to 7500 mg

Methocarbamol (10 tablets) daily may be taken.

Elderly patients

Elderly patients may only need half the usual dose to give the same relief from the pain and muscle spasms.

Liver problems

You may need a longer interval between taking the tablets if you have liver disease.

You should always follow your doctor’s instructions carefully.

How to take the tablets

Methocarbamol is for oral use. The tablets should be taken with a glass of water (approx. 200 ml).

How long should you take the tablets

The duration of treatment depends on your symptoms but should not exceed 30 days.

If you take more Methocarbamol than you should

Please contact your doctor immediately. He-she will decide what to do.

If you forget to take Methocarbamol

Do not take a double dose to make up for a forgotten dose. Please take the next dose at the usual time.

If you stop taking Methocarbamol

Please tell your doctor if you wish to stop your treatment with Methocarbamol. There are unlikely to be any unwanted effects on stopping your treatment.

If you have any further questions on the use of this medicine, ask your doctor or pharmacist.

Package leaflet: Information for the patient

Methocarbamol 750 mg Tablets Methocarbamol

Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.

  • Keep this leaflet. You may need to read it again.
  • If you have any further questions, ask your doctor or pharmacist.
  • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.
  • If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

Rare side effects (may affect up to 1 in 1,000 people)

  • conjunctivitis
  • headache
  • dizziness
  • metallic taste
  • decrease in blood pressure
  • swelling of the nasal mucosa
  • angioedema (a serious allergic reaction which causes swelling of the face or throat)
  • rash
  • itching
  • urticaria (itchy skin)
  • fever.

Very rare side effects (may affect up to 1 in 10,000 people)

  • anaphylactic reactions (allergic hypersensitivity reactions)
  • loss of appetite
  • restlessness
  • anxiety
  • confusion
  • fainting
  • nystagmus (rapid, uncontrollable eye movements)
  • drowsiness
  • tremor
  • convulsions
  • blurred vision
  • double vision
  • slowed heartbeat
  • hot flush
  • feeling sick
  • vomiting.

Side effects with unknown frequency (frequency cannot be estimated from the available data)

  • sleepiness
  • loss of coordination
  • local temporary sensory disorders (predominantly in the area of the face, scalp, lips, hands, fingers or feet),
  • nausea
  • diarrhoea
  • fatigue.

Reporting of side effects

If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects you can help provide more information on the safety of this medicine.

5. How to store Methocarbamol

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date which is stated on the carton and the blister after EXP. The expiry date refers to the last day of that month.

This medicine does not require any special storage conditions.

Do not throw away any medicines via waste water or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help to protect the environment.

6. Contents of the pack and other information

What Methocarbamol tablets contain

The active substance is methocarbamol. Each tablet contains 750 mg

methocarbamol.

The other ingredients are sodium starch glycolate (type A), magnesium stearate and povidone K25.

What Methocarbamol looks like and contents of the pack

Methocarbamol 750 mg tablets are white, slightly convex, oblong tablets.

Methocarbamol is available in packs containing 20, 50 and 100 tablets. Not all pack sizes may be marketed.

Marketing Authorisation Holder and Manufacturer

Aristo Pharma GmbH

Wallenroder Str. 8-10

13435 Berlin

Germany

This leaflet was last revised in 11/2024.

GI917000-10/UK/1124 50014213/1

CustomerAristo Pharma GmbH
Product NameMethocarbamol 750mg tablets PIL UK
MarketUnited Kingdom (UK)
Language/sEnglish
n/a
50014213/1
Manufacturer CodeGI917000-10/UK/1124
Our RefMethocarbamol_750mg_tablets_PIL_ UK_ver11 — (** to follow final proof)
Issue11
Date19 March 2025
SPECIFICATION DETAILS
Origination13 December 2021 — (as Issue 01)
165 x 580 mm
Border12 mm
661 (Placement to be verified)
Font detailsMain title: Frutiger LT Std - 75 Black - 18pt Sub-titles: Frutiger LT Std - 75 Black — 12 pt Body copy: Frutiger LT Std - 55 Roman — 10 pt
Black - K

About this document

Source: MHRA - Medicines and Healthcare products Regulatory Agency (products.mhra.gov.uk) · Marketing authorisation: PL 40546/0160

Last revision stated in the text: November 2024 · MHRA data as of 13 October 2026

Found a mistake? Tell us on the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Facts about Methocarbamol Aristo 750 mg tablet

Prescription needed? Yes, prescription-only medicine (POM)
Active substance Methocarbamol
Strength 750 mg
Pharmaceutical form Oral tablet
White, oblong tablets (19 mm x 8 mm)
How is it taken Oral
Excipients Sodium starch glycolate (type A) Magnesium stearate, Povidone K25
Pack sizes 100 tablet
Is it available? Listed as available (NHS Dictionary of Medicines and Devices – not a record of current supplies)
Shelf life 3 years
Storage This medicinal product does not require any special storage conditions.
Drug group (ATC) Muscle relaxants, centrally acting agents, carbamic acid esters
  1. M Musculo-skeletal system drugs
    1. M03 Muscle relaxants
      1. M03B Muscle relaxants, centrally acting agents
        1. M03BA Carbamic acid esters, centrally acting muscle relaxants
          1. M03BA03 methocarbamol
Marketing authorisation PL 40546/0160 (first authorised 4 October 2022)
Marketing authorisation holder Aristo Pharma GmbH
Codes GTIN 4251575902725 · BNF 10020200

Sources: the MHRA product information (products.mhra.gov.uk) and the NHS Dictionary of Medicines and Devices (dm+d), release 10.2.0 of 19 October 2026, NHS Business Services Authority. Contains public sector information licensed under the Open Government Licence v3.0.